StockData
Solid Biosciences Inc. logo

Solid Biosciences Inc. (SLDB) stock

SLDBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 7/30
$6.23−0.25 (-3.86%)

Close on Nov 17, 2026Market cap $668.01MP/E –Yield –

Solid Biosciences price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Solid Biosciences's price to sales ratio was 23.7× on Feb 29, 2024, against 8.1× a year earlier. Over the last 2 years it ranged from 3.0× to 23.7×, with a median of 7.0×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2024Feb 29, 202423.7×+8.4
2023Dec 29, 202315.2×+12.2
2022Dec 30, 20223.0×–

More Solid Biosciences figures

See a number that looks wrong?